WHO ICTRP trial
Vaccination med autologe dendritiske celler pulset med allogent tumorlysat…
EUCTR2006-002202-54-DK · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2006-002202-54-DK |
|---|---|
| Public title | Vaccination med autologe dendritiske celler pulset med allogent tumorlysat (MelCancerVac) til behandling af patienter med avanceret eller metastatisk ikke-småcellet lungecancer - MelCancerVac_NSCLC |
| Scientific title | Vaccination med autologe dendritiske celler pulset med allogent tumorlysat (MelCancerVac) til behandling af patienter med avanceret eller metastatisk ikke-småcellet lungecancer - MelCancerVac_NSCLC |
| Primary sponsor | Dandrit Biotech A/S |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Denmark |
| Conditions | avanceret eller metastatisk ikke-småcellet lungecancer MedDRA version: 7.1 Level: PT Classification code 10029520 |
| Interventions | Pharmaceutical Form: Injection* Current Sponsor code: MelCancerVac Other descriptive name: autologe dendritiske celler pulset med allogent tumorlysat Concentration type: equal Concentration number: 0,2 ml-injektion |
| Registration date | May 19, 2006 |
| Target size | 50 |
| Secondary IDs | Dandrit 02, April 2006 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: